Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent T Ho

Showing results (91-100 of 227) with videos related to

Pageof 23
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2012
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysisJoshua A Hill, Sophia Koo, Belisa B Guzman Suarez, et al.
The Lancet. Haematology|December 22, 2015
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre studyJohn E Levine, Thomas M Braun, Andrew C Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantationJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood Advances|May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHDKatie Maurer, Vincent T Ho, Eno Inyang, et al.
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Pageof 23

Showing results (91-100 of 227) with videos related to

Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2012
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysisJoshua A Hill, Sophia Koo, Belisa B Guzman Suarez, et al.
The Lancet. Haematology|December 22, 2015
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre studyJohn E Levine, Thomas M Braun, Andrew C Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantationJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood Advances|May 8, 2023
Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHDKatie Maurer, Vincent T Ho, Eno Inyang, et al.
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Blood|April 29, 2004
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationVincent T Ho, David Zahrieh, Ephraim Hochberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell LymphomaAlex F Herrera, Lu Chen, Sirin Khajavian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host diseaseSarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Blood|January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseStefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Pageof 23